Akari Therapeutics Announces Oral Presentation of Nomacopan Phase II Data in Patients with Bullous Pemphigoid at the 28th European Academy of Dermatology and Venereology (EADV) Congress, October 9-13, 2019
Stock Information for Akari Therapeutics Plc
Loading
Please wait while we load your information from QuoteMedia.